C

CTC Bio Inc
KOSDAQ:060590

Watchlist Manager
CTC Bio Inc
KOSDAQ:060590
Watchlist
Price: 4 470 KRW -1.54% Market Closed
Market Cap: ₩108.1B

Operating Margin

4.1%
Current
Improving
by 6.4%
vs 3-y average of -2.4%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
4.1%
=
Operating Income
₩5.6B
/
Revenue
₩137.4B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
4.1%
=
Operating Income
₩5.6B
/
Revenue
₩137.4B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
CTC Bio Inc
KOSDAQ:060590
106.9B KRW
Loading...
US
Eli Lilly and Co
NYSE:LLY
972.2B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
547.5B USD
Loading...
CH
Roche Holding AG
SIX:ROG
277.1B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.4B GBP
Loading...
CH
Novartis AG
SIX:NOVN
219B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
272.1B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
148.3B USD
Loading...
FR
Sanofi SA
PAR:SAN
93.8B EUR
Loading...

Market Distribution

In line with most companies in Korea
Percentile
58th
Based on 2 615 companies
58th percentile
4.1%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

CTC Bio Inc
Glance View

Market Cap
108.1B KRW
Industry
Pharmaceuticals

CTC Bio, Inc. engages in the manufacture of pharmaceuticals, functional food and animal health products. The company is headquartered in Hongcheon, Gangwon-Do. The company went IPO on 2002-02-21. The company pharmaceuticals include anticancer agents, antibiotics, bone injury treatments, antiulcer agents, blood flow stimulants and others. Its veterinary drugs include vaccines, antibiotics, immune enhancers, enzymes, organic acid, avian influenza-related agents and others. Its animal feed supplements include pigments, kapok seed meal, sesame meal and others. Its functional food business includes the development and manufacture of enzymes, lactobacillus and related products mainly used in dairy products. The company also involves in the development of pharmaceutical manufacturing technology and know-how. The firm distributes its products within domestic market and to overseas markets.

CTC Bio Inc Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
4.1%
=
Operating Income
₩5.6B
/
Revenue
₩137.4B
What is CTC Bio Inc's current Operating Margin?

The current Operating Margin for CTC Bio Inc is 4.1%, which is above its 3-year median of -2.4%.

How has Operating Margin changed over time?

Over the last 3 years, CTC Bio Inc’s Operating Margin has decreased from 7.1% to 4.1%. During this period, it reached a low of -11% on Jun 30, 2024 and a high of 7.1% on Aug 30, 2022.

Back to Top